BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33317623)

  • 1. Convergent network effects along the axis of gene expression during prostate cancer progression.
    Charmpi K; Guo T; Zhong Q; Wagner U; Sun R; Toussaint NC; Fritz CE; Yuan C; Chen H; Rupp NJ; Christiansen A; Rutishauser D; Rüschoff JH; Fankhauser C; Saba K; Poyet C; Hermanns T; Oehl K; Moore AL; Beisel C; Calzone L; Martignetti L; Zhang Q; Zhu Y; Martínez MR; Manica M; Haffner MC; Aebersold R; Wild PJ; Beyer A
    Genome Biol; 2020 Dec; 21(1):302. PubMed ID: 33317623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression.
    Latonen L; Afyounian E; Jylhä A; Nättinen J; Aapola U; Annala M; Kivinummi KK; Tammela TTL; Beuerman RW; Uusitalo H; Nykter M; Visakorpi T
    Nat Commun; 2018 Mar; 9(1):1176. PubMed ID: 29563510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
    Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
    Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study.
    Ross-Adams H; Lamb AD; Dunning MJ; Halim S; Lindberg J; Massie CM; Egevad LA; Russell R; Ramos-Montoya A; Vowler SL; Sharma NL; Kay J; Whitaker H; Clark J; Hurst R; Gnanapragasam VJ; Shah NC; Warren AY; Cooper CS; Lynch AG; Stark R; Mills IG; Grönberg H; Neal DE;
    EBioMedicine; 2015 Sep; 2(9):1133-44. PubMed ID: 26501111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
    Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
    Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer.
    O'Hurley G; Busch C; Fagerberg L; Hallström BM; Stadler C; Tolf A; Lundberg E; Schwenk JM; Jirström K; Bjartell A; Gallagher WM; Uhlén M; Pontén F
    PLoS One; 2015; 10(8):e0133449. PubMed ID: 26237329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
    Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations.
    Böttcher R; Kweldam CF; Livingstone J; Lalonde E; Yamaguchi TN; Huang V; Yousif F; Fraser M; Bristow RG; van der Kwast T; Boutros PC; Jenster G; van Leenders GJLH
    BMC Cancer; 2018 Jan; 18(1):8. PubMed ID: 29295717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Proteogenomic Landscape of Curable Prostate Cancer.
    Sinha A; Huang V; Livingstone J; Wang J; Fox NS; Kurganovs N; Ignatchenko V; Fritsch K; Donmez N; Heisler LE; Shiah YJ; Yao CQ; Alfaro JA; Volik S; Lapuk A; Fraser M; Kron K; Murison A; Lupien M; Sahinalp C; Collins CC; Tetu B; Masoomian M; Berman DM; van der Kwast T; Bristow RG; Kislinger T; Boutros PC
    Cancer Cell; 2019 Mar; 35(3):414-427.e6. PubMed ID: 30889379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral and Intertumoral Genomic Heterogeneity of Multifocal Localized Prostate Cancer Impacts Molecular Classifications and Genomic Prognosticators.
    Wei L; Wang J; Lampert E; Schlanger S; DePriest AD; Hu Q; Gomez EC; Murakam M; Glenn ST; Conroy J; Morrison C; Azabdaftari G; Mohler JL; Liu S; Heemers HV
    Eur Urol; 2017 Feb; 71(2):183-192. PubMed ID: 27451135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mutational landscape of prostate cancer.
    Barbieri CE; Bangma CH; Bjartell A; Catto JW; Culig Z; Grönberg H; Luo J; Visakorpi T; Rubin MA
    Eur Urol; 2013 Oct; 64(4):567-76. PubMed ID: 23759327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Proteogenomic Characterization across Major Histological Types of Pediatric Brain Cancer.
    Petralia F; Tignor N; Reva B; Koptyra M; Chowdhury S; Rykunov D; Krek A; Ma W; Zhu Y; Ji J; Calinawan A; Whiteaker JR; Colaprico A; Stathias V; Omelchenko T; Song X; Raman P; Guo Y; Brown MA; Ivey RG; Szpyt J; Guha Thakurta S; Gritsenko MA; Weitz KK; Lopez G; Kalayci S; Gümüş ZH; Yoo S; da Veiga Leprevost F; Chang HY; Krug K; Katsnelson L; Wang Y; Kennedy JJ; Voytovich UJ; Zhao L; Gaonkar KS; Ennis BM; Zhang B; Baubet V; Tauhid L; Lilly JV; Mason JL; Farrow B; Young N; Leary S; Moon J; Petyuk VA; Nazarian J; Adappa ND; Palmer JN; Lober RM; Rivero-Hinojosa S; Wang LB; Wang JM; Broberg M; Chu RK; Moore RJ; Monroe ME; Zhao R; Smith RD; Zhu J; Robles AI; Mesri M; Boja E; Hiltke T; Rodriguez H; Zhang B; Schadt EE; Mani DR; Ding L; Iavarone A; Wiznerowicz M; Schürer S; Chen XS; Heath AP; Rokita JL; Nesvizhskii AI; Fenyö D; Rodland KD; Liu T; Gygi SP; Paulovich AG; Resnick AC; Storm PB; Rood BR; Wang P; ;
    Cell; 2020 Dec; 183(7):1962-1985.e31. PubMed ID: 33242424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome sequencing in prostate cancer identifies inter-tumor heterogeneity.
    Mendonca J; Sharma A; Kachhap S
    Asian J Androl; 2015; 17(3):435-6. PubMed ID: 25532579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer.
    Malihi PD; Graf RP; Rodriguez A; Ramesh N; Lee J; Sutton R; Jiles R; Ruiz Velasco C; Sei E; Kolatkar A; Logothetis C; Navin NE; Corn P; Aparicio AM; Dittamore R; Hicks J; Kuhn P; Zurita AJ
    Clin Cancer Res; 2020 Aug; 26(15):4143-4153. PubMed ID: 32341031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral heterogeneity and genetic characteristics of prostate cancer.
    Wu B; Lu X; Shen H; Yuan X; Wang X; Yin N; Sun L; Shen P; Hu C; Jiang H; Wang D
    Int J Cancer; 2020 Jun; 146(12):3369-3378. PubMed ID: 32159858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.